• UME is trusted supplier of FDA-approved antibody, antigen test kits
• United moved quickly to address growing needs created by COVID-19
• Company dedicated to providing guidance to aging population, their families and medical staff supporting them

United Medical Equipment Business Solutions Network is a company focused on the needs of aging patients and veteran communities as well as those impacted by the COVID-19 pandemic. United is a trusted supplier of FDA-approved antibody and antigen test kits, medical equipment and personal protective equipment (“PPE”). As the world attempts to control this pandemic, it is essential to quickly identify who is infected and who has already been infected. Antibody testing determines whether or not a patient has had COVID-19 in the past while antigen testing determines whether or not a patient currently has COVID-19.

An antibody test can help determine how many people have had and recovered from COVID-19. This includes those that were asymptomatic. Since individuals are presenting various symptoms, ranging from no symptoms to full respiratory failure, symptoms alone cannot accurately confirm if someone has been infected. Antibody tests have limited use in detection but help to determine accurate case numbers and research into immunity.

The antigen rapid test allows for quick diagnosis that can help curb the spread of the virus. Antigens are a specific protein that sits on the surface of the virus. These rapid tests identify antigens when the individual is contagious. That individual can then be placed into quarantine, stopping the spread of the virus (https://ibn.fm/xB6J7).

The FDA-approved CareStart(TM) COVID-19 Antigen Rapid POC test is part of United’s answer in combating the spread of the virus. The test is administered by medical professionals to detect COVID-19 antigens. This test identifies acute infection with 88.4% sensitivity and 100% specificity, and helps provide critical answers about active infections to patients and healthcare workers alike (https://ibn.fm/Q8js4).

United moved quickly to address the growing needs created by the COVID-19 pandemic. In addition to providing test kits, COVID-19 supplies and products (https://ibn.fm/KgD8i), and PPE equipment with flexible payment options, the company has acted as a trusted senior referral source for independent living, assisted living, hospice, memory care, skilled nursing and senior care centers.

Throughout 2020 and into 2021, the elderly have been particularly vulnerable to this pandemic. United is dedicated to providing guidance for the aging population, their families, and the medical community that serves them.

For more information, visit the company’s website at www.UnitedMedSolutions.com.

NOTE TO INVESTORS: The latest news and updates relating to United Medical Equipment are available in the company’s newsroom at https://ibn.fm/UnitedMed

• TAAT(TM) partnered with CROSSMARK based on powerful formula for creating, implementing and executing strategies for CPG merchandising
• Of particular interest is CROSSMARK’S success in commercializing tobacco alternatives that achieved dominant e-cigarette market share
• TAAT committed to growing innovative tobacco-free, nicotine-free alternative to traditional cigarettes

TAAT Lifestyle & Wellness (CSE: TAAT) (OTCQB: TOBAF), a life science company dedicated to giving legal-aged smokers a nicotine- and tobacco-free smoking experience, recently unveiled TAAT(TM), its flagship product — and the product has been greeted with an exceptional response. Representative of the interest shown in the product — and the promising future of the innovative smoking alternative — is the agreement TAAT recently signed with CROSSMARK, an omnichannel CPG sales agency. “Ever since TAAT was first placed on store shelves in Ohio in December 2020, we have received glowing feedback about the product from both legal-aged smokers and retailers alike,” said TAAT CEO Setti Coscarella. “It is common knowledge in the world of business that this is only the first step towards the success of a product launch. We selected CROSSMARK to represent TAAT because their formula for creating, implementing and executing strategies for CPG merchandising has been honed over decades of bringing new consumer products to mainstream retail channels.” Through CROSSMARK, all three TAAT varieties — Original, Smooth and Menthol —may be available at more than 100,000 convenience stores located throughout the country. CROSSMARK, a sales and merchandising agency for CPG products, has established relationships with major retailers across all channels. Of particular interest to TAAT is CROSSMARK’S success in commercializing tobacco alternatives that achieved dominant e-cigarette market share in the United States. “At CROSSMARK, we pride ourselves in our familiarity with what intrigues today’s consumers and what consistently delivers value to them,” said Jeff Neihart. CROSSMARK vice president and general manager of customer service. “We are very selective in onboarding only a limited number of new brands each year, and it gives me great satisfaction to have found a match in TAAT as a novel, relevant, and ‘sticky’ product that could continue to resonate well with legal-aged smokers. “Furthermore, we are confident that with the combination of our presence in the retail channels through which tobacco products are sold and our experience in executing strategies within the category of tobacco alternatives, we can amplify the value proposition offered by TAAT to legal-aged smokers in the United States and help the company meet or exceed their goals,” Neihart continued. “CROSSMARK has been in the business of connecting retailers with a curated range of CPG products for more than 100 years, and we are excited to introduce TAAT to tobacco retailers who we predict will find the product appealing and will want to carry it in their respective stores.” According to the agreement, in addition to introducing TAAT to potential wholesale and retail locations, CROSSMARK will provide an in-field execution team focused on supporting in-store acceptance, merchandising and reorders of TAAT products. The company will also provide TAAT with extensive promotional, trade marketing and analytics support as the two companies partner together to make the most of existing initiatives and evaluate the possibilities for national growth and expansion. “In addition to leveraging their relationships with major retailers and wholesalers across our targeted channels for TAAT, CROSSMARK also offers an impressive suite of ‘back office’ functions including marketing, data analytics, and order processing support,” said Coscarella. “Altogether, these services could enable TAAT to penetrate the tobacco market much more rapidly and efficiently compared to building out our own national sales and merchandising team from scratch. One only has to look at the results CROSSMARK achieved in commercializing another tobacco brand across the United States to know that they have both the experience and know-how to launch a product to an audience of legal-aged smokers, which could assist the company in realizing its objectives for the TAAT product launch. We are thrilled to have CROSSMARK on our side as we seek to make TAAT products available to legal-aged smokers throughout the United States.” TAAT has developed TAAT, a tobacco-free and nicotine-free alternative to traditional cigarettes offered in Original, Smooth and Menthol varieties. TAAT’s base material is Beyond Tobacco, a proprietary blend that undergoes a patent-pending refinement technique causing its scent and taste to resemble tobacco. Under executive leadership with Big Tobacco pedigree, TAAT was launched in the United States in Q4 2020 and is focused on positioning itself in the $814 billion global tobacco industry. For more information, visit the company’s website at www.TAATGlobal.com. NOTE TO INVESTORS: The latest news and updates relating to TOBAF are available in the company’s newsroom at https://ibn.fm/TOBAF

• Industry experts expect rare earth elements (“REE”) space to continue to grow significantly through 2030
• UUUU entered REE business last year to complement its core uranium production; plans commercial production of intermediate REE product in H1 2021
• Company expects to become leading U.S. player in this field, supplying up to 50% of nation’s rare earth demand in next few years

The rare earth elements (“REE”) market continues to be of interest for investors and governments around the world amid the heightened uncertainty due to trade restrictions out of China and increased demand for REE magnets, according to an article published by “Investing News Network” (https://ibn.fm/HfbHa). The sector provides the critical metals required for clean energy technologies and electronics that penetrates many segments of both the consumer and business spaces. As the country’s largest uranium producer and the leading critical minerals producer, Energy Fuels (NYSE American: UUUU) (TSX: EFR) has entered the REE space, committed to domestically supplying another critical mineral needed to making the new Biden Administration’s clean energy goals a reality.

After the initial hit to prices in the first half of 2020 as lockdowns and containment measures in China impacted the global supply chains, the REE space rebounded strongly in the second half of the year. And it appears that the sector’s growth will not stop there.

REEs, used in many tech devices and clean energy technologies such as smartphones, wind turbines and electric vehicles, will be critical for the sector over the next decade. Although REE’s supply and demand dynamics are still uncertain due to the pandemic, most analysts are optimistic for 2021 and beyond.

The push for the sector comes as Western countries continue to create supply chains less dependent on China. The article cites David Merriman of Roskill, a commodity research firm, who expects electric and hybrid vehicles’ drivetrains and wind turbine — which all use rare earth permanent magnets — to drive the sector’s robust growth for the remainder of the decade. For example, it is expected that REE demand for automotive applications will grow around 26.5% year-on-year in 2021.

Adamas Intelligence, a research firm focused on strategic metals and minerals, also expects demand to bounce back for nearly all end-use categories for rare earth elements in 2021. Global passenger battery EV, plug-in hybrid EV and hybrid EV sales are expected to drive the growth, increasing collectively by 20 to 40% year over year.

In April 2020, UUUU set out to penetrate the REE market as a complement to its core uranium product lines. Since the announcement of the expansion into REE business, the company has made significant strides, quickly becoming an emerging player in the space. Its initial goal is to enter the commercial REE business in H1 2021 and to supply up to 50% of U.S. rare earth demand contained in a mixed REE concentrate over the next few years.

The company also has plans to install REE separation, and perhaps additional downstream capabilities, over the next few years. The ambitious plans are to be achieved with the company’s existing infrastructure (https://ibn.fm/XhQAQ). With its expansion into the growing REE market and all debt paid off last year, the company is leveraging a robust business model that allows it to be well positioned to capitalize on the increasing momentum for the REE space.

For more information, visit the company’s website at www.EnergyFuels.com.

NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU

• PlantX to display and sell its indoor plants at Farm Cup Coffee’s highly attractive West Hollywood location
• The careful partnership aligns perfectly with PlantX’s commitment to supporting healthy lifestyles and community empowerment
• PlantX opens wide the potential of indoor plants, making it both easy and appealing to discover what the world of plants can provide

As the digital face of the plant-based community, PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) is taking another step to solidify its position as a one-stop shop for everything plant-based. The Company recently announced that has entered into a new collaboration with Farm Cup Coffee, an innovative coffee shop that offers organic coffee that is ethically sourced from farm owners around the world. PlantX will display and sell its houseplants at Farm Cup Coffee’s new physical location in West Hollywood, California (https://ibn.fm/TADOE).

“Displaying our indoor plants in the highly attractive Farm Cup Coffee store in West Hollywood will expand PlantX’s reach to its customers and boost our brand visibility,” said PlantX founder Sean Dollinger. “We are thrilled to collaborate with the Farm Cup Coffee team, whose passion for sustainability is echoed by PlantX’s aim to inspire people to adopt healthier, more eco-friendly lifestyles.”

PlantX anticipated that the collaboration will heighten its presence in one of L.A.’s most sought-after retail locations. The company will be displaying a wide range of indoor plants, from succulents to an exotic variety of potted flora. The carefully thought-out partnership aligns perfectly with PlantX’s commitment to supporting healthy lifestyles and community empowerment.

Indoor plants are only a fresh and beautiful introduction to what PlantX offers. The Company’s mission is to raise plant awareness in a hyper-palatable world to simplify plant-based living. PlantX lives its mission by striving to deliver the highest-quality products with the best service available.

And the PlantX product offering is widespread. From its line of indoor plants, which are now on display at Farm Cup Coffee, to its groceries, meal deliveries and plant-based gifts, the Company opens wide the potential of plants, making it both easy and appealing to discover what the world of plants can provide.

Partnering with Farm Cup Coffee in this endeavor was a no-brainer. The brand, which began in a Citroen van outfitted as a mobile and stylish coffee shop, focuses on positivity and is committed to sustainability. “We not only want you to drink good coffee, we want you to feel good drinking it too,” said Farm Cup Coffee co-founder Tony Yuan. “This harmonious partnership with PlantX at our West Hollywood location will help promote a happy and sustainable lifestyle for the local community.

With its fast-growing category verticals, PlantX offers customers across North America more than 10,000 plant-based products. In addition to offering meal and indoor plant deliveries, the company currently has plans to expand its product lines to include cosmetics, clothing and its own water brand. PlantX uses its digital platform to build a community of like-minded consumers and, most importantly, provide education.

To learn more about this company, visit www.PlantX.com, www.PlantX.ca and www.Investor.Plantx.com and view the PlantX for Plant-Based Investors.

NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

• POAI subsidiary inks contract with significant pharmaceutical company
• TumorGenesis announces sale of media to research medical centers in New York City, Boston
• Potential market for 3D cancer cell culture media expected to reach $3.2 billion sales worldwide by 2027

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, announced that one of its wholly owned subsidiaries, Soluble Biotech, recently inked another contract with a large pharmaceutical company (https://ibn.fm/OpaJb). POAI also announced that TumorGenesis, one of its wholly owned subsidiaries, has sold media to two top research medical centers (https://ibn.fm/uXorQ).

Soluble Biotech’s contract will involve using the company’s proprietary protein formulation technology to improve the solubility and stability of a protein therapeutic destined for future clinical use.

“This opportunity may also lead to a long-term relationship whereby Soluble Biotech develops a strategic partnership to support several other therapeutics currently under development within the pharmaceutical company,” said Soluble Biotech Founder and President Dr. Larry DeLucas.

In additional company news, Predictive Oncology shared details about the sale of media to two top research medical centers. The sales by TumorGenesis, POAI’s wholly owned subsidiary, were repeat orders from hospitals in New York City and Boston, and included culturing ovarian cancer cells with specific research goals.

“We believe that this is the future of ovarian cancer research, which creates new possibilities to coming up with new treatments for this chronic and deadly disease,” said Predictive Oncology President and CEO Dr. Carl Schwartz. “In order for us to find better drugs, we have to be able to grow the right patient cells in the right media. Building the ‘living library’ of cancer cells for drug screening and discovery is the right first step.” POAI is committed to this first step and is the process of building the largest existing database of drug response data in the world.

The announcement noted that TumorGenesis can replicate ovarian cancer cells in a laboratory—outside of the patient’s body. The company has 15 ovarian cancer cell lines along with the media to grow those cells.

“These tissues, in the right TumorGenesis media, replicate not only the DNA/RNA and proteomic signatures but also replicate the histological structures that can be seen in staining, outside the patient’s body,” said TumorGenesis President and board member Richard Gabriel. The process produces invaluable information that can be used by oncologists and other cancer treatment experts to potentially identify and prescribe treatments and care for cancer patients, resulting in more positive outcomes.

The potential market for what POAI does — 3D cancer cell culture media — is expected to reach $3.2 billion sales worldwide by 2027. The space is so explosive because it currently offers the best available models for cancer drug discovery and development.

POAI is bringing precision medicine, or tailored medical treatment using the individual characteristics of each patient, to the treatment of cancer. Through its Helomics division, the company leverages its unique, clinically validated patient derived (“PDx”) smart tumor profiling platform to provide oncologists with a road map to help individualize therapy. In addition, the company is leveraging artificial intelligence and its proprietary database of more than 150,000 cancer cases tumors to build AI-driven models of tumor drug response to improve outcomes for the patients of today and tomorrow.

For more information, visit the company’s website at www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

• Gage Cannabis recently closed on Regulation A equity financing offering, raising gross proceeds of $50 million
• Issuance was oversubscribed, resulted in addition of over 1,000 new investors to Gage Cannabis’ shareholder base
• Gage Cannabis plans to use the proceeds to further expand Gage’s retail reach, pursue M&A opportunities and help solidify the company’s position as one of the leading operators in the state of Michigan
• Company also announced appointment of Richard Mavrinac to Board of Directors

Gage Growth Corp. (d.b.a. Gage Cannabis) (“Gage Cannabis”), a leading vertically integrated cannabis operator currently focused exclusively on the Michigan market, recently announced that it had successfully concluded its Regulation A, Tier 2, equity financing offering. The equity issuance consisted of Gage Cannabis issuing 28,571,400 subordinate voting shares for total gross proceeds of $50 million, the maximum amount qualified under the company’s offering circular. The offering was oversubscribed by both institutional and retail investors and has led to a significant expansion of the company’s shareholder base through the addition of over 1,000 new investors (https://ibn.fm/gPEro). “We are humbled and excited by the significant interest and investor demand we received for our oversubscribed Reg A financing,” said Gage Cannabis President Fabian Monaco. “Michigan is one of the fastest growing cannabis markets in the United States, and Gage is well positioned with a robust balance sheet to continue to grow our market share as the leading operator with the best brands in the state. This is a great first step in our journey to becoming a publicly traded company, and we’re excited to continue to drive long-term shareholder value.” Gage Cannabis has been one of the prime beneficiaries from Michigan’s move to legalize the use of recreational marijuana in December 2019. Since then, Gage Cannabis has pursued an aggressive expansion plan, which has seen the company open 6 medical or adult-use locations across the state, with a further 10+ locations slated to open in 2021. The company’s rapidly expanding footprint has been largely predicated on the strong underlying sales growth witnessed within the sector. Cannabis retailers sold approximately $450 million worth of recreational marijuana products in the state of Michigan over the twelve months following the legalization decision on December 1, 2019, an achievement which was significantly boosted by the Michigan State Government’s decision to nominate the cannabis industry as an ‘essential sector’ during the COVID-19 outbreak (https://ibn.fm/YsVHi). Remarkably, the sector’s sales have continued to thrive, rising to a run-rate of over $13 million a week in recent months (https://ibn.fm/umNmb). Should that rate be maintained, sales growth for the sector could rise by nearly 400 percent year-over-year to approximately $1.6 billion over the course of the next year. “It really is just explosive growth in Michigan,” stated Sloane Barbour, the chief revenue officer of cannabis industry recruitment agency FlowerHire (https://ibn.fm/nBNua). Gage Cannabis plans to use the proceeds from its recently closed Regulation A equity financing to further cement a dominant position within the Michigan state marijuana industry by expanding its retail footprint and pursuing accretive acquisitions which could assist in further expanding their market share. The company has also stated its intent to pursue a potential go-public transaction, which it expects to complete in the first quarter of 2021. In addition to the equity issuance, Gage Cannabis also seized on the opportunity to update investors on a recent addition to the company’s Board of Directors. Richard Mavrinac, formerly the CFO of George Weston Limited and Executive Vice President of Loblaw Companies Limited, two of Canada’s largest companies operating in the retail grocery and bakery sectors, will be joining Gage Cannabis’ board to assist the company on its future growth strategy. Mr. Mavrinac is also a member of the Board of Directors of TerrAscend Corp., Roots Corporation and Canopy Rivers Inc., and will bring a significant wealth of experience within the retail and cannabis sector to Gage Cannabis executive team. For more information, visit the company’s website at www.GageUSA.com. NOTE TO INVESTORS: The latest news and updates relating to Gage Cannabis are available in the company’s newsroom at https://ibn.fm/GAGE

• Founders Robert A. Rositano Jr. and Dean Rositano have over 25 years of experience that includes the first-ever Internet IPO and World Wide Web Directory
• The Rositano brothers released a disruptive social network, nettaxi.com, before Facebook became popular, exiting the industry with approximately a $700 million market cap
• Fan Pass recently appointed media and digital advertising expert John Haugh as the VP of sales, operations, and business development
• Friendable Inc. plans to continue expanding and innovating the Fan Pass platform, addressing all artist needs and desires through their platform and Pro Serives

Since being founded by entrepreneurial brothers Robert A. Rositano Jr. and Dean Rositano, mobile technology and marketing company Friendable (OTC: FDBL) has leveraged their expertise and over 25 years of experience in tech-related startups, to release flagship product Friendable, followed by a second application, Fan Pass, to great success. With an impressive background in team building and turning ideas into big business opportunities, the Rositano brothers have raised over $65+ million in capital that spans various companies. Their history dates back to the first-ever Internet IPO, Netcom Online Communications. They are also responsible for developing the first-ever World Wide Web Directory, which was sold to McMillan Publishing. Before Facebook, they deployed the first mover social network, nettaxi.com, which exited with a market cap of approximately $700 million. The two have leveraged their extensive experience to create Friendable’s first product, Friendable, a social application that facilitates one-on-one and group-style meets that create non-threatening and all-inclusive meeting settings. The focus of the application is to build subscription-based revenue where “everything starts with friendship.” This was followed by the company’s second application, Fan Pass, launched in July 2020. In the middle of a global pandemic, Friendable released a subscription service that provides fans with an “All Access VIP” option, including:

• Live performances and online concerts
• Backstage access to artists for meetups – before, during, and after events
• Livestreams of in-studio sessions
• Behind-the-scenes footage of video and photoshoots
• Special interviews with one-on-one video experiences
• Streams that highlight the daily lives of the artist

Fan Pass’s intuitive platform brings each artist on, providing them with a streamlined channel, livestream space, and merchandise that can be offered exclusively through the Fan Pass merchandise store. Knowing that artists rely on their revenue streams, each artist who comes on board receives a portion of the revenue from the subscriptions and pay-per-view events. Fans pay a monthly fee of $3.99 for daily access to the artists on the platform. The VIP experiences are available at a fraction of the cost of traditional face-to-face encounters. Pay-per-view concert events are livestreamed straight to your smart device, cheaper than in-person concert tickets. While kicking off the February 2021 promotional period earlier this month, Friendable announced the addition of John Haugh to the Fan Pass team (https://ibn.fm/oM4UZ). Mr. Haugh joined the team as the VP of sales, operations, and business development. He has over 25 years of experience and over 10,000 touring miles to bring to the team, having been a musical performance artist. He has had regular correspondence with familiar industry names such as WEA, Sony Music, Universal, Atlantic, RED Distribution, Warner Brothers, Virgin Music, and more. Mr. Haugh also brings with him an extensive repertoire representing advertising agencies and marketing managers, securing advertising dollars and relationships with notable companies like Nissan and Intel. He has handled event partnerships and national media purchases with multi-million dollar budgets. These experiences provided him with a powerful vision for the shift to digital marketing. “We are blessed and excited to have Mr. Haugh join our team,” Friendable CEO Robert A. Rositano Jr. said about Haugh’s appointment. “He has firsthand knowledge of what it takes to be a touring music artist and, even more importantly, understands the pain points of artists and where Fan Pass can be the most supportive as we continue with our platform updates, new features, revenue opportunities, and overall growth plans for the Company.” For more information, visit the company’s websites at www.Friendable.com or www.FanPassLive.com. NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

• InsuraGuest renews InsuraGuest Hospitality Liability coverages contract with Wintergreen resort
• InsuraGuest recently expanded platform integration to about 82 different property management systems connecting with all the big names in the hospitality sector
• InsureThePeople is integrating innovation and technology to deliver to the U.S small business market

InsuraGuest Technologies (TSX.V: ISGI) (OTCQB: ISGIF)  is an insurtech (insurance+technology) company engaged in delivering digital insurance to multiple sectors through its proprietary software platform. The company harnesses the power of technology to deliver insurance digitally across all sectors, empowering clients by offering on-demand insurance products. Insuraguest Technologies recently announced the renewal of its annual contract with Wintergreen Resort in Wintergreen, Virginia, to supply its InsuraGuest Hospitality Liability coverages to the hotel Resort. This specialized guest protection policy is the first line of defense for both the property and the guest (https://ibn.fm/ob2jP). The hotels and rental properties who enroll in the InsuraGuest Hospitality Liability coverages. require their guests to pay a nominal fee at the time of check-in. InsuraGuest then pays out these small claims, shifting the burden from the hotel operator. With no surge in premium prices, there is no impact on the company’s liability policy. With InsuraGuest Hospitality Liability specialized coverages, properties benefit from an additional layer of protection in case a guest encounters an accident, room-damage, theft, or property damage. This prevents the need to make GL claims if an InsuraGuest-covered claim occurs and reduces the hassle, saving time and money for hotel and vacation rental properties. InsuraGuest utilizes a proprietary software platform to deliver these specialized Hospitality Liability coverages. Through its proprietary API, InsuraGuest syncs about 82 different property management systems that allow companies to transfer certain liability exposures to the InsuraGuest carrier (https://ibn.fm/evDmc). InsureThePeople helps small-businesses identify their insurance needs and provides them with on-demand affordable policies. It utilizes InsuraGuest’s proprietary insurtech platform to deliver these customized policies using automation and digital solutions in less than 60 seconds. InsureThePeople hopes to leverage the market of small businesses that make up 99% of America’s 28.7 million businesses. Further, the entrepreneur and freelance markets include 64.8 million people and will reach 90 million by 2028, with an estimated value of $1.8 billion. The last decade has witnessed an investment of $16.5 billion in insurtech, with the emergence of insurtech startups and a sharp increase in fundraising. Insurtech startups are entering the domain of the big players by focusing on meeting the changing consumer demands through increased personalization, greater speed, and accuracy of services through technology. A recent Forbes article (https://ibn.fm/jNL6t) outlines this technological innovation in the digital insurance sector. While InsuraGuest systems already target niche markets like the hospitality sector, the company is geared to extend its services to broader audiences to generate additional revenue streams. For more information, visit the company’s website at www.InsuraGuest.com. NOTE TO INVESTORS: The latest news and updates relating to ISGI are available in the company’s newsroom at http://ibn.fm/ISGI

• With Mediscan, the option of having scanning equipment at patient’s location is becoming increasingly viable
• Patent-pending Mediscan software converts ultrasound analog 2D grayscale image into digital 3D HD format
• Software can generate quality 3D medical images of broad variety of organs, including heart, lungs, tendons, skin and nerves

Since its introduction into the world of medicine, the ultrasound has become one of the most efficient, reliable ways to examine the human body in a noninvasive way. And now, this medical mainstay has become even more essential in providing quality care — proprietary technology from HYB Holding (OTC: HYBG) subsidiary Mediscan Inc. can transform traditional 2D images from a portable ultrasound machine into invaluable 3D images to provide even more accurate internal views and, consequently, better diagnosis and health care. “Ultrasounds give an accurate image of body parts in the least amount of time, and even allow the patient to experience real-time results,” reported a recent Mediscan blog. “In fact, [ultrasounds] can produce a high-definition image in less than ten seconds.” That turnaround time is impressive, especially when compared to technologies such as CTs and MRIs, which can take anywhere from 24 hours to an entire week before results are available. The speed of ultrasounds becomes even more critical during emergencies, when the ability to have point-of-care ultrasound (“POCUS”) can save lives. Thanks to Mediscan, the option of having scanning equipment at a patient’s location — whether that is in an ambulance, at an assisted-living facility or even at a patient’s own home — is becoming increasingly viable. Fundamentally, the Mediscan software converts an ultrasound analog 2D grayscale image into a digital 3D HD format. This transformation can take place in traditional ultrasound locations; the Mediscan application integrates with all popular EMR systems. In addition, because the software is designed to pair with portable ultrasound machines, it can be used in less traditional settings. The exclusive software can provide valuable insight to on-the-scene medical professionals, such primary care physicians, specialists and technical support staff, as well as sports trainers, emergency medical services (EMS) personnel, and technicians in isolation wards and emergency rooms. The process is simple. This patent-pending, cloud-based software application for ultrasound devices is easy to use wherever the internet is available. Once an image has been captured in 2D, it is converted using a cloud-based software application process. The now-3D image can be viewed on a computer monitor, pad or smartphone at the point of service, providing the convenience of point-of-care ultrasound with the image quality of CT or X-ray and the safety of expensive MRI technology. The software can generate quality 3D medical images of a broad variety of organs, including the heart, lungs, tendons, skin and nerves. HYB Holding, through its subsidiary Mediscan Inc., offers technology that can transform 2D images from a portable ultrasound machine into digital 3D images to provide better diagnosis and more accurate internal trauma views. The technology has multiple applications in lung, cardiac and musculoskeletal imaging and related uses. For more information, visit the company’s website at www.MyMediScan.com. NOTE TO INVESTORS: The latest news and updates relating to HYBG are available in the company’s newsroom at https://ibn.fm/HYBG

• Knightscope, Inc. designs, engineers, builds, deploys, and services autonomous data machines (“ADMs”) also known as security robots
• It currently offers three operational robots in the U.S.: K1 Stationary, K3 Indoors, and K5 Outdoors
• The robots are cheaper for clients per hour compared to human guards and run 24/7
• Knightscope charges between $4 and $11 per hour for its machines on annual contracts, while security companies can charge between $15 and $35 an hour for an unarmed guard and about $85 per hour for an armed guard, according to Knightscope’s CEO
• Investors can purchase shares in Knightscope through its Reg A+ offering
• Since its inception in 2013, Knightscope has generated over $10 million in revenue

Knightscope, a private company that designs, engineers, builds, deploys, and services security robots under the Machine-as-a-Service (“MaaS”) model, aims to woo clients and investors with its cost-effective autonomous data machines (“ADMs”). The California-based company, which was established in 2013, has so far raised $70 million from over 20,000 investors and four major corporations. It is eyeing a possible public listing on NASDAQ under the ticker symbol ‘KSCP’. Knightscope currently offers three operational autonomous machines, namely K1, K3, and K5. K1 is a stationary ADM ideal for indoor and outdoor use at ingress and egress areas, while the latter two are mobile. K3 is designed for indoor usage, while K5 is an outdoor-only ADM. According to its Securities and Exchange Commission (“SEC”) filings, Knightscope earns a revenue ranging between $4,500 and $6,000 per month per ADM. It has so far generated over $10 million in revenue since its inception in 2013 from clients who include hospitals, Fortune 1000 companies, and law enforcement agencies (https://ibn.fm/n7x0i). In a bid to drum up support for its Reg A+ offering, which allows investors to purchase shares in Knightscope today, and to show why clients would be interested in the security robots, William Santana Li, Knightscope’s Chairman and Chief Executive Officer, compared his company’s products to human security guards. According to Li, clients would pay about $85 per hour for an armed guard and between $15 and $35 an hour for an unarmed guard if they chose to go that route. However, in an interview with IPO Edge, Li claimed that his company offers “a technology and a Machine-as-a-Service business model at an effective price of $4 to $11 an hour.” “Most security teams look like a cost center for their clients. They don’t generate revenue, (are) not necessarily brand-enhancing, are usually on the chopping block, and (get) limited budget and resources until something goes wrong. Then they get accused of not doing their job.” Li continued. He termed such a situation as difficult for an organization. He further noted that his company is an attractive option for clients, given that “Folks are either limited on budget or looking genuinely for cost reduction. So, if you’re burning $150 million a year on security guards, you’re going to want to look at it (Knightscope’s services and products)” (https://ibn.fm/QsV10). Li also debunked the conjecture that $4 and $11 an hour would be too low an amount to compel someone to invest in Knightscope. “We sign year-long contracts running 24/7. So, each machine will generate on the order of $70,000 and $100,000 per annum. It costs us less than $60,000 to build the machine. So, the idea is to recover the cost of the machine in the first calendar years, and then the second, third, fourth, fifth year you are basically printing money.” Taking maintenance and service costs, cellular charges, and system upgrade costs into account, Santana estimates that each machine could generate up to $250,000 in profit over five years. The ADMs have numerous capabilities. They provide real-time access to data round the clock. For example, in a year, the machines generate over 90 terabytes of data that can be used for analysis purposes. And that’s not all. They also have features such as 360-degree eye-level HD video streaming, thermal anomaly detection, automatic license plate recognition (at a rate of 1,200 plates per minute), people detection, facial recognition (even for people wearing masks), and automatic signal detection. While the CEO’s utterances show promise and demonstrate Knightscope’s ideal prospects, the SEC filings tell a different story. Knightscope has been operating in the red. In the six months ending June 2019 and June 2020, the company reported net losses of $6.99 million and $9.14 million, respectively. Further, in the six months that followed, Knightscope posted $11.96 million and $13.39 million in net losses for the period ending December 2019 and December 2020, respectively. Knightscope CEO stated that the Company has built all of its technology from scratch and is now raising capital to scale the business to profitability. For more information, visit the company’s website at www.Knightscope.com. Visit www.Knightscope.com/invest for a summary of Knightscope as an investment, with a blue Instant Messaging button for direct contact with their CEO. DISCLAIMER: You should read the Offering Circular and risks related to this offering before investing. This Reg A+ offering is made available through StartEngine Primary, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. NOTE TO INVESTORS: The latest news and updates relating to Knightscope are available in the company’s newsroom at https://ibn.fm/Knight